AU2003287290A1 - Fluorescense based bioassay for anti-parasitic drugs - Google Patents

Fluorescense based bioassay for anti-parasitic drugs

Info

Publication number
AU2003287290A1
AU2003287290A1 AU2003287290A AU2003287290A AU2003287290A1 AU 2003287290 A1 AU2003287290 A1 AU 2003287290A1 AU 2003287290 A AU2003287290 A AU 2003287290A AU 2003287290 A AU2003287290 A AU 2003287290A AU 2003287290 A1 AU2003287290 A1 AU 2003287290A1
Authority
AU
Australia
Prior art keywords
fluorescense
based bioassay
parasitic drugs
parasitic
drugs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003287290A
Inventor
Todd L. Capson
Jose Del C. Gonzalez
Eduardo Ortega-Barria
Yolanda Corbett Rodriguez
Liuris Herrera Valderrama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smithsonian Tropical Research Institute
Original Assignee
Smithsonian Tropical Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithsonian Tropical Research Institute filed Critical Smithsonian Tropical Research Institute
Publication of AU2003287290A1 publication Critical patent/AU2003287290A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18Testing for antimicrobial activity of a material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/44Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from protozoa
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/44Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from protozoa
    • G01N2333/445Plasmodium
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003287290A 2003-09-11 2003-10-30 Fluorescense based bioassay for anti-parasitic drugs Abandoned AU2003287290A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50184503P 2003-09-11 2003-09-11
US60/501,845 2003-09-11
PCT/US2003/034513 WO2005035783A1 (en) 2003-09-11 2003-10-30 Fluorescense based bioassay for anti-parasitic drugs

Publications (1)

Publication Number Publication Date
AU2003287290A1 true AU2003287290A1 (en) 2005-04-27

Family

ID=34434833

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003287290A Abandoned AU2003287290A1 (en) 2003-09-11 2003-10-30 Fluorescense based bioassay for anti-parasitic drugs

Country Status (2)

Country Link
AU (1) AU2003287290A1 (en)
WO (1) WO2005035783A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009103128A1 (en) * 2008-02-21 2009-08-27 The University Of Sydney Detection of anti-parasitic compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2636995A (en) * 1994-05-18 1995-12-05 Research And Development Institute, Inc. Simple, rapid method for the detection, identification and enumeration of specific viable microorganisms
US5516905A (en) * 1994-08-30 1996-05-14 University Of Massachusetts Medical Center Antibiotic compounds and methods to treat gram-positive bacterial and mycoplasmal infections
WO2001034830A2 (en) * 1999-11-08 2001-05-17 Lumitech (Uk) Limited Assay of micro-organisms in cell cultures

Also Published As

Publication number Publication date
WO2005035783A1 (en) 2005-04-21

Similar Documents

Publication Publication Date Title
EP1545662B8 (en) Drug delivery system
AU2003291103A1 (en) Pharmaceutical composition
AU2003290524A1 (en) Nanoparticle delivery system
AU2003268087A1 (en) Liposomal gemcitabine compositions for better drug delivery
AU2003901813A0 (en) Pharmaceutical derivatives
AU2003260668A1 (en) Biological affinity based delivery systems
AU2003250372A1 (en) Pharmaceutical composition
AU2003245504A1 (en) Pharmaceutical compositions for drugs having ph-dependentsolubility
AU2002364468A1 (en) Solid orally-dispersible pharmaceutical formulation
AU2002353435A1 (en) Medication administration system
AU2003210553A1 (en) Substance delivery device
AU2003217782A1 (en) Dna-binding polyamide drug conjugates
AU2003211586A1 (en) Drugs containing riboflavin-type compounds
AU2003261801A1 (en) Novel depsipeptide compound
AU2002333276A1 (en) Drugs for vasculopaties
AU2003285550A1 (en) Drug delivery system
AU2003287290A1 (en) Fluorescense based bioassay for anti-parasitic drugs
AU2003302320A1 (en) Seterocyclic quinones as pharmaceutical agents
GB0204392D0 (en) Pharmaceutical compound
GB0310361D0 (en) Pharmaceutical compound
AU2002342940A1 (en) New pharmaceutical compounds
AUPS188302A0 (en) Pharmaceutical composition
EP1701949B8 (en) Assay for entactogens
AU2003303963A1 (en) Drug target
AUPS155402A0 (en) Administration system

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase